Cargando…
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
Rheumatoid arthritis (RA) is a chronic systemic autoimmune condition which affects approximately 1% of the adult population worldwide and is characterized by joint inflammation, with extra-articular features being common. Interleukin 6 (IL-6) is one of the chief pro-inflammatory cytokines found in t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883250/ https://www.ncbi.nlm.nih.gov/pubmed/27747493 http://dx.doi.org/10.1007/s40744-014-0007-2 |